Evidence map›Paper›PMID 39093404›Full record

ArticleCancer immunology, immunotherapy : CII2024

Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.

Siqi Cai, Guanqun Yang, Mengyu Hu, Chaozhuo Li, Liying Yang, Wei Zhang, Jujie Sun, Fenghao Sun, Ligang Xing, Xiaorong Sun

Abstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Which dominates recurrence: tumor or microenvironment?Journal of translational medicine · 2025
    Article
  7. Development and Validation of a Predictive Nomogram for Early Postoperative Recurrence in Non-Small Cell Lung Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  8. Closer proximity of pre-treatment CD4Translational lung cancer research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Siqi CaiShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Guanqun YangShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Mengyu HuShandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Chaozhuo LiSchool of Clinical Medicine, Weifang Medical University, Weifang, Shandong, China.
Liying YangShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Wei ZhangShandong Cancer Hospital and Institute and Shandong Academy of Medical Science, Jinan, Shandong, China.
Jujie SunDepartment of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Fenghao SunDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No.440, Jiyan Road, Huaiyin District, Jinan, 250117, Shandong, China.
Ligang XingShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Xiaorong SunShandong University Cancer Center, Shandong University, Jinan, Shandong, China. xrsun@sdfmu.edu.cn.

Funding

Department of Science & Technology of Shandong Province NO. 2021CXGC011102National Natural Science Foundation of China NO. 82172866Natural Science Foundation of Shandong Province NO. ZR2021LZL005Natural Science Foundation of Shandong Province ZR2019LZL019Start-up Fund of Shandong Cancer Hospital 2020PYA04
6 · The paper itself

Abstract

backgroundThe interplay between regulatory T cells (Tregs) and neighboring cells, which is pivotal for anti-tumor immunity and closely linked to patient prognosis, remains to be fully elucidated.

methodsTissue microarrays of 261 operable NSCLC patients were stained by multiplex immunofluorescence (mIF) assay, and the interaction between Tregs and neighboring cells in the tumor microenvironment (TME) was evaluated. Employing various machine learning algorithms, we developed a spatial immune signature to predict the prognosis of NSCLC patients. Additionally, we explored the interplay between programmed death-1/programmed death ligand-1 (PD-1/PD-L1) interactions and their relationship with Tregs.

resultsSurvival analysis indicated that the interplay between Tregs and neighboring cells in the invasive margin (IM) and tumor center was associated with recurrence in NSCLC patients. We integrated the intersection of the three algorithms to identify four crucial spatial immune features [P

conclusionWe dissected the cell interplay network within the TME, uncovering the spatial architecture and intricate interactions between Tregs and neighboring cells, along with their impact on the prognosis of NSCLC patients.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoplasm Recurrence, LocalT-Lymphocytes, RegulatoryTumor MicroenvironmentAgedB7-H1 AntigenFemaleHumansLymphocytes, Tumor-InfiltratingMaleMiddle AgedPrognosisProgrammed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanProgrammed Cell Death 1 ReceptorCell spatial interplay networkLung cancerMultiplex immunofluorescenceRegulatory T cellTumor microenvironment

Identifiers

PMID39093404
PMCPMC11297009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.